Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophageus

NCT04435197 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT04435197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04435197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophageus
Lead sponsor
Ruijin Hospital
Phase
Phase 2
Overall status
Completed
Start date
August 11, 2020
Completion date
June 30, 2024
Enrollment
143 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal squamous cell carcinoma